Common Contracts
3 similar Employment Agreement contracts by Neogenix Oncology Inc
A Cancer Therapeutics & Diagnostics Company phone: (516) 482 1200 fax: (516) 482 3848Employment Agreement • April 30th, 2010 • Neogenix Oncology Inc • New York
This letter dated May 5, 2009 is to confirm our understanding with respect to your employment by Neogenix Oncology, Inc. or any present or future parent, subsidiary or affiliate thereof (collectively, the “Company”). The terms and conditions agreed to in this letter are hereinafter referred to as the “Agreement.” In consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, we have agreed as follows:
A Cancer Therapeutics & Diagnostics Company phone: (240) 314 0596Employment Agreement • April 30th, 2010 • Neogenix Oncology Inc • Maryland
This letter dated May 5, 2009 is to confirm our understanding with respect to your employment by Neogenix Oncology, Inc. or any present or future parent, subsidiary or affiliate thereof (collectively, the “Company”). The terms and conditions agreed to in this letter are hereinafter referred to as the “Agreement.” In consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, we have agreed as follows:
A Cancer Therapeutics & Diagnostics Company phone: (516) 482 1200 fax: (516) 482 3848Employment Agreement • April 30th, 2010 • Neogenix Oncology Inc • New York
This letter dated May 5, 2009 is to confirm our understanding with respect to your employment by Neogenix Oncology, Inc. or any present or future parent, subsidiary or affiliate thereof (collectively, the “Company”). The terms and conditions agreed to in this letter are hereinafter referred to as the “Agreement.” In consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, we have agreed as follows:
